1465044-60-3

Upstream product

• 1465044-58-9 5-isopropyl-2,4-bis((4-methoxybenzyl)oxy)benzaldehyde 
• 1826-67-1 vinyl magnesium bromide 
• 958888-27-2 5-isopropyl-2,4-dihydroxy benzaldehyde 
• 824-94-2 p-methoxybenzyl chloride 

Downstream Products

• 1465044-62-5 1-(5-isopropyl-2,4-bis((4-methoxybenzyl)oxy)phenyl)prop-2-en-1-one 
• 1465044-65-8 1-(5-isopropyl-2,4-bis((4-methoxybenzyl)oxy)phenyl)-4-(pyridin-3-yl)butane-1,4-dione 
• 1465044-67-0 4-(4-(2-(5-isopropyl-2,4-bis((4-methoxybenzyl)oxy)phenyl)-5-(pyridin-3-yl)-1H-pyrrol-1-yl)phenyl)morpholine 
• 1465044-47-6 4-isopropyl-6-(1-(4-morpholinophenyl)-5-(pyridin-3-yl)-1H-pyrrol-2-yl)benzene-1,3-diol 

Relevant academic research and scientific papers

NOVEL TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY

The present invention relates to novel triazole Hsp90 inhibitors that possess significant inhibitory activity against Hsp90, which are suitable for the treatment of hyperproliferative diseases such as cancer, infections, immune disorders, inflammation, and CNS related disorders. Furthermore, pharmaceutical compositions, including combination products, are also provided in the present application. Further provided are methods of using the pharmaceutical compositions and/or combination products.